Teva-Furosemide · DIN 00337749 · 40 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Teva-Furosemide · DIN 00337749
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Health Canada: Marketed since 2012-07-11 · brand TEVA-FUROSEMIDE · ATC C03CA01 FUROSEMIDE · form Tablet · route Oral · ingredients FUROSEMIDE 40 MG · company Teva canada limited · schedule Prescription
Teva-Furosemide: Formulary list price $0.03 per unit (the source does not state the unit; exact figure $0.0327). What the ministry pays, not the patient.
Ministry pays: $0.0327 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00337749)
Source record
DIN 00337749: Teva-Furosemide
Raw flags: chronicUseMed=Y, sec3=Y
Item: 402800009; group id 559; item number 1499; lccId None; manufacturer id TEV
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.0327; ministry $0.0327
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00337749
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2447
Interchangeable products
Apo-Furosemide · DIN 00362166 · $0.0327
Furosemide · DIN 02351439 · $0.0327
Lasix · DIN 02224704 · not recorded
Mint-Furosemide · DIN 02466767 · $0.0327
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00337749
Shortage record checked October 6, 2026